AgomAb Therapeutics NV (AGMB) Retained Earnings (2024 - 2026)
Agomab Therapeutics' Retained Earnings was -$247.14 million in Q2 2026.
Powered by 
Analysis
AgomAb Therapeutics NV (AGMB) Retained Earnings (2024 - 2026) Analysis & Trends
At the end of FY2025, Retained Earnings at Agomab Therapeutics came in at -$205.3 million.
- In earlier years, Retained Earnings was -$128.99 million in FY2024.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -242.85 Mn |
| Dec 31, 2025 | -213.46 Mn |
| Dec 31, 2024 | -124.02 Mn |
API Access
AgomAb Therapeutics NV Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=AGMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "AGMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=AGMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();